CJ
UTHR icon

Caitlin John’s United Therapeutics UTHR Stock Holding History

Caitlin John’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.8K Sell
68
-343
-83% -$193K 0.02% 403
2026
Q1 		$244K Sell
411
-546
-57% -$272K 0.15% 135
2025
Q4 		$466K Buy
+957
New +$446K 0.31% 72

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Caitlin John's UTHR Position: Q2 2026 in Review

Caitlin John reduced its United Therapeutics (UTHR) stake by 83% in Q2 2026, selling an estimated $193K and leaving 68 shares worth $36.8K. The position accounts for 0.02% of the portfolio, ranked #403.

Caitlin John first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $466K in Q4 2025. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Caitlin John held 68 shares of United Therapeutics worth $36.8K as of Q2 2026.
  • Caitlin John sold 343 United Therapeutics shares in Q2 2026, an estimated $193K.
  • United Therapeutics made up 0.02% of Caitlin John's portfolio in Q2 2026, its #403 holding.
  • Caitlin John first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Caitlin John's United Therapeutics position peaked at $466K in Q4 2025.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.